The incoming issue of the Journal comes with an interesting group of papers revolving around a provocative topic: work from Seattle on the absence of predictive value of standard pulmonary function tests in LVAD surgery. Vivek Rao takes the opportunity to present his thoughts in this brief editorial, the important central message of which cannot be
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Basic science
October 30, 2017
A detailed review of the pericardial sinuses on the occasion of discovery of a unilateral pericardial fold caudal to Marshall's ligament. The significance of the structure is discussed as an operating surgical note to ipsilateral pericardial traction/ elevation in beating heart surgery.
October 18, 2017
The authors report the non-intuitive finding that blood from female donors who had ever been pregnant was associated with increased mortality among male recipients (HR 1.13). If validated by other studies, might this substantially complicate matching donated blood with appropriate recipients? Clearly the underlying mechanism will be interesting to
October 13, 2017
Patient Care
September 13, 2017
Remote perconditioning at the hindlimb and terminal warm blood cardioplegia provide synergistic cardioprotection for cardioplegic arrest in an in vivo piglet model.
August 21, 2017
An editorial on what will be soon required from papers sent to the Circulation group of periodicals, and probably soon to all reputable biomedical journals. Bolli advances that the internal and external validity of manuscripts has space for improvement!
August 11, 2017
Patient Care
A heart team at Kingston Health Sciences Centre in Ontario performs the first hybrid cardiac ablation for atrial fibrillation in Canada.
July 21, 2017
Patient Care
July 18, 2017
In this study, the Dabigatran reversal-drug Idarucizumab was tested. 503 patients were enrolled, of whom 202 had to undergo an urgent procedure. Of the patients requiring an urgent procedure, the median time of initiation of the procedure was 1.6 hours, and at that time periprocedural hemostasis was assessed as normal in 93.4% of the patients.
June 22, 2017
The Amsterdam Investigator-initiated Absorb Strategy All-comers Trial report safety concerns identified in early results for the bioresorbable scaffold drug eluting stent. The scaffold group experienced significantly higher rates of device thrombosis than the stent group (3.5% vs 0.9%; p<0.001).